Antibody-Drug Conjugates, ADCs

Booth No: M104

Characteristic

Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the field of biological therapy. ADCs utilize monoclonal antibodies (mAbs) to specifically target antigens and deliver a highly potent cytotoxic agent to the tumor cell (for cancer treatment). After the ADCs are internalized, the cytotoxic drug is released and kills the cell. By this approach, the drug has fewer side effects and gives a wider therapeutic window than traditional cytotoxic agents. Although ADC technology is well-established as a superior treatment for cancer, its potential use in HIV treatment remains largely unexplored.

Menu

Antibody-Drug Conjugates, ADCs

Characteristic

Other Products

Products you may be interested in

Highest Rated Products